CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE25624.15161.95 (+0.64 %)
PREV CLOSE () 25462.20
OPEN PRICE () 25417.15
BID PRICE (QTY) 25583.20 (1)
OFFER PRICE (QTY) 25627.90 (1)
VOLUME 351
TODAY'S LOW / HIGH ()25200.05 25624.15
52 WK LOW / HIGH ()20594.25 29628.15
NSE25300.00-152.55 (-0.6 %)
PREV CLOSE() 25452.55
OPEN PRICE () 25549.95
BID PRICE (QTY) 25291.10 (48)
OFFER PRICE (QTY) 25299.95 (1)
VOLUME 14116
TODAY'S LOW / HIGH() 25200.00 25549.95
52 WK LOW / HIGH ()20605.05 29638.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1944

Management Info :

Munir Shaikh - Chairman - Managing Director

Registered Office :

Address : Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone : 022-50461000 / 2000 / 67978888

Website : www.abbott.co.in

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
12Apr Abbott India informs about appointment
In compliance with Regulation 30 of the Securities and Exchange Board of..
27Mar Abbott India informs about newspaper a
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
19Mar Abbott India informs about resignation
With reference to its earlier communication dated December 19, 2023, whe..
15Mar Abbott India informs about change in s
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Sche..
13Mar Abbott India informs about change in d
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Sche..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit3109.89494.1
Gross Profit 4221.6 12738.2
Operating Profit 443313597.8
Net Sales 14371.453487.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddy's Lab (BSE)
 6132.95 (3.05%)
M.Cap ( in Cr)
102088.61
NGL Fine-Chem (BSE)
 2766.60 (5.56%)
M.Cap ( in Cr)
1701.83
Bharat Parenterals (BSE)
 1670.00 (7.94%)
M.Cap ( in Cr)
971.88
Alkem Laboratories (BSE)
 4812.45 (2.13%)
M.Cap ( in Cr)
57443.81
Vimta Labs (BSE)
 574.85 (12.84%)
M.Cap ( in Cr)
1279.46
Shareholding Pattern
PROMOTERS 74.99%
NON-INSTITUTION 15.92%
MUTUAL FUNDS/UTI 7.57%
FI/BANKS/INSURANCE 1.23%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74171.50318.56 (0.43%)
NIFTY22520.90118.50 (0.53%)
Dow Jones 38460.92-42.77 (-0.11%)
Nasdaq 15712.7516.11 (0.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI